| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
ILMN
Illumina
|
Oct 30, 2026 | BUY |
Buy
-10.0% avg upside
32 analysts
|
$300.00
27.12% Upside
|
-14.1% | Β· |
|
AVTR
Avantor
|
Oct 29, 2026 | HOLD |
Buy
+4.5% avg upside
27 analysts
|
$17.00
5.96% Upside
|
-9.0% | Β· |
|
RGEN
Repligen
|
Oct 29, 2026 | BUY |
Strong Buy
+1.3% avg upside
25 analysts
|
$205.00
15.87% Upside
|
-13.7% | Β· |
|
ICLR
Icon
|
Oct 29, 2026 | HOLD |
Strong Buy
-1.8% avg upside
28 analysts
|
$200.00
5.44% Downside
|
-9.5% | Β· |
|
IQV
IQVIA Holdings
|
Oct 28, 2026 | BUY |
Strong Buy
-2.5% avg upside
40 analysts
|
$325.00
21.61% Upside
|
-7.7% | Β· |
|
QGEN
Qiagen
|
Oct 22, 2026 | HOLD |
Buy
-10.6% avg upside
25 analysts
|
$52.00
3.61% Upside
|
-0.8% | Β· |
|
TMO
Thermo Fisher
|
Oct 22, 2026 | BUY |
Strong Buy
-5.2% avg upside
40 analysts
|
$820.00
17.58% Upside
|
+1.8% | Β· |
|
DHR
Danaher
|
Oct 22, 2026 | BUY |
Strong Buy
-4.4% avg upside
47 analysts
|
$270.00
16.22% Upside
|
-1.8% | Β· |
|
CRL
Charles River Labs
|
Oct 16, 2026 | BUY |
Strong Buy
-28.4% avg upside
36 analysts
|
$345.00
4.09% Downside
|
+10.7% | Β· |
|
MTD
Mettler-Toledo
|
Oct 16, 2026 | HOLD |
Buy
-26.0% avg upside
19 analysts
|
$1550.00
7.38% Downside
|
+5.8% | Β· |
|
RVTY
Revvity
|
Oct 16, 2026 | HOLD |
Buy
-20.0% avg upside
25 analysts
|
$155.00
1.34% Downside
|
-2.4% | Β· |
|
WAT
Waters
|
Oct 16, 2026 | HOLD |
Strong Buy
-12.6% avg upside
31 analysts
|
$435.00
6.05% Downside
|
+2.9% | Β· |
|
TXG
10x Genomics
|
Oct 16, 2026 | HOLD |
Buy
-7.6% avg upside
19 analysts
|
$70.00
0.13% Downside
|
-21.3% | Β· |
|
BRKR
Bruker
|
Oct 14, 2026 | HOLD |
Buy
+4.9% avg upside
22 analysts
|
$60.00
5.04% Upside
|
+10.4% | Β· |
|
QDEL
QuidelOrtho
|
Oct 14, 2026 | SELL |
Buy
+195.9% avg upside
13 analysts
|
$12.00
9.35% Downside
|
+28.8% | Β· |
|
ADPT
Adaptive Biotechnologies
|
Oct 14, 2026 | BUY |
Strong Buy
+2.0% avg upside
17 analysts
|
$30.00
12.63% Upside
|
+11.2% | Β· |
|
TEM
Tempus AI, Inc. Class A
|
Oct 14, 2026 | HOLD |
Strong Buy
-0.3% avg upside
25 analysts
|
$70.00
3.16% Downside
|
-7.2% | Β· |
|
CAI
Caris Life Sciences, Inc.
|
Oct 14, 2026 | BUY |
Strong Buy
-9.5% avg upside
21 analysts
|
$35.00
2.01% Upside
|
-34.1% | Β· |
|
SHC
Sotera Health
|
Oct 14, 2026 | SELL |
Buy
+20.0% avg upside
13 analysts
|
$17.00
6.34% Downside
|
+9.5% | Β· |
|
GH
Guardant Health
|
Oct 14, 2026 | BUY |
Strong Buy
-3.1% avg upside
33 analysts
|
$195.00
8.97% Upside
|
-12.1% | Β· |
|
NTRA
Natera
|
Oct 14, 2026 | BUY |
Strong Buy
-13.3% avg upside
28 analysts
|
$460.00
11.03% Upside
|
-27.2% | Β· |
|
A
Agilent
|
Aug 27, 2026 | BUY |
Strong Buy
-8.0% avg upside
35 analysts
|
$190.00
8.73% Upside
|
+9.8% | Β· |
|
ALMR
Alamar Biosciences, Inc.
|
Aug 10, 2026 | BUY |
Strong Buy
+9.2% avg upside
5 analysts
|
$35.00
14.37% Upside
|
+9.5% | Β· |
|
BLLN
BillionToOne, Inc. Class A
|
Aug 06, 2026 | BUY |
Strong Buy
+12.2% avg upside
10 analysts
|
$130.00
14.69% Upside
|
+6.4% | Β· |
|
OSUR
Orasure Technologies
|
Aug 09, 2024 | HOLD |
Buy
+111.5% avg upside
12 analysts
|
$5.00
26.83% Upside
|
-34.1% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.